A CTO choosing between an in-house measurement system and a vendor platform needs evidence that either choice improves software delivery, not a prettier account of code quality. I would buy the measurement plumbing first, then replace it only if a controlled trial exposes gaps that matter. The purchase earns its place when teams can trace changes in production outcomes to specific engineering work—and trust the underlying data.
A measurement purchase should begin with a falsifiable bet
“Better technical health” is too elastic to test. Before inviting vendors or assigning an internal build team, write down the operational change the measurement system is supposed to enable. For example: identifying risky services early should reduce time spent repairing escaped defects without increasing the delay between an approved change and its release. That is a bet a CTO can reject with evidence.
Choose a narrow decision the new system will support: which services receive refactoring capacity next quarter, which release controls need adjustment, or where additional review is worth its cost. Name the person who will act on the result. A metric with no decision attached is a reporting expense because nobody can say what different reading would have changed.
Code Quality Metrics to Improve Technical Health provides candidate indicators, but I would not turn an inventory of code measures into a procurement scorecard because coverage, duplication and static-analysis findings can improve while escaped defects remain unchanged. Treat those indicators as explanations to investigate. Make the buying criterion an outcome they might help predict.
A workable trial has three layers. First, record the intervention: which teams received risk rankings, whether they looked at them, and which decisions changed. Second, measure proximal effects, such as the age of unresolved high-severity findings on changed code and the share of flagged pull requests that received an additional review. Third, measure outcomes: escaped defects per production change, time to restore service after a change-related incident, and the elapsed time from approval to production. Keeping these layers separate prevents a tool from claiming success merely because people opened its dashboard.
For planning, give the pilot 8 weeks; that is a proposed trial length, not a universal benchmark, and it may need extending where releases are infrequent. Set the intervention rule before launch—for instance, review the highest-risk 20% of changed services each week. That percentage is a threshold to tune against reviewer capacity. Record exceptions, since an unreviewed alert cannot reasonably be credited or blamed for a later result.
A rising quality score does not establish that delivery improved
Large programs produce tempting before-and-after charts. They also change staffing, release frequency and incident policy while the chart is rising. A CTO should therefore compare an exposed group with a credible unexposed group over the same period. Match services on recent change volume, incident history and ownership stability, then assign the trial so the least troubled services do not all receive the new tool. If assignment cannot be randomized, document the differences rather than hiding them in a composite score.
Measuring Success in Large-Scale Software Projects: Insights is useful context, but I would not accept a program-level success measure as proof that a measurement purchase worked because an on-time release can conceal a growing repair burden. Keep the trial’s primary outcome close to the decision the tool was purchased to improve.
Take change-related repair time as one example. In the synthetic observations below, pilot services move from 40 to 28 hours while comparison services move from 32 to 27. The pilot’s raw improvement is 12 hours, but the comparison improves by 5 hours too; the adjusted difference is 7 hours. These are demonstration figures, not field measurements. This Python 3 snippet runs as written and prints the adjusted change:
hours = {
"pilot": {"before": 40, "after": 28},
"control": {"before": 32, "after": 27},
}
def change(group):
return hours[group]["after"] - hours[group]["before"]
adjusted = change("pilot") - change("control")
print(f"Adjusted repair-time change: {adjusted} hours")
That calculation is a starting point, not a causal certificate. Parallel trends may fail if pilot services receive a major rewrite while comparison services do not. Review pretrial trends, log concurrent migrations, and report uncertainty when there are too few incidents to distinguish a real effect from noise. For rare failures, inspect individual cases alongside the aggregate rather than announcing a percentage improvement based on a handful of events.
Define denominators before collecting results. “Defects per release” can improve merely because releases become larger; defects per production change has a different weakness when changes vary greatly in size. Publish both the numerator’s classification rule and the denominator. DORA’s change failure rate and time to restore service can provide common language, while GitHub pull-request timestamps and deployment records provide more auditable event boundaries. Neither substitutes for checking whether teams changed their release behavior to make the numbers look better.
I would not pay a vendor to produce one technical-health score, because its weighting can conceal the trade-off between fewer incidents and slower delivery. A score may help someone find a service to inspect; it should not be the acceptance test for the purchase.
Broken event lineage should fail the trial before ROI is calculated
A credible result requires a chain from a code change to a deployment, an incident or defect, and the decision made using the tool. Ask both vendor and internal-build teams to reconstruct that chain for a sampled change without manual detective work. GitHub’s GraphQL API or GitLab’s REST API can supply merge events; Jira Cloud issue records can supply defect classification; deployment events from GitHub Actions or Argo CD can establish when code reached production. OpenTelemetry trace context may help locate the affected service, but a trace alone does not prove which commit introduced a fault.
Specify join rules in writing. A pull request merged into a branch is not necessarily a production change. A Jira ticket closed this week may describe a defect introduced months ago. Preserve source identifiers, event time, ingestion time and any correction history so an analyst can see why a record moved between reporting periods. Where services share a repository, map deployments to service versions rather than assigning every repository-level finding to every service.
Make the quality signals reproducible as well. CodeQL can export SARIF 2.1.0 findings, which lets a buyer inspect rule IDs and locations instead of accepting a vendor’s opaque severity count. SonarQube quality gates can separate findings on new code from inherited debt, which matters because a team cannot clear years of backlog during a short pilot. SPDX 2.3 or CycloneDX 1.6 can identify dependency changes, while SLSA v1.0 provenance can support checks on build origin. These standards improve portability only when the vendor actually exports the underlying identifiers and history, so test an export rather than accepting a compatibility badge.
Set a data-completeness gate before viewing outcome charts. One possible acceptance threshold is 95% of production deployments linked to a source revision; that is an adjustable operating target, and a lower figure may be defensible for a poorly instrumented estate at the start of a trial. Check missing links by team and service, not just in aggregate, because a single well-instrumented group can mask the absence of data from the most troubled system.
Also test revisions. Reclassify a sample incident, force a delayed deployment event, and remove a duplicate webhook delivery. If the reported result changes silently, the platform cannot support a procurement decision because leadership cannot tell whether the improvement came from engineering or data cleanup.
Buying wins until an in-house build passes a specific exit test
The explicit comparison is LinearB versus a PostgreSQL 16, dbt Core and Grafana build. LinearB wins when its connectors, definitions and exports survive the lineage checks and the CTO needs a trial running sooner than an internal data team can deliver one. Its costs are subscription spend, connector upkeep, contract review and the risk that a proprietary definition becomes difficult to reproduce. The in-house stack wins when event definitions are unusually specific, data residency rules exclude a vendor, or a durable analytics team already owns the pipelines. Its costs are engineer time, identity mapping, schema maintenance, dashboard design and an ongoing obligation to explain every broken join.
Do not compare the invoice with the salary of one engineer. For a decision model, suppose the vendor route costs an illustrative $60,000 over the evaluation and first operating year, while an internal build consumes an estimated $110,000 of fully loaded engineering time before maintenance. Neither figure is a quoted price or a measured saving. Replace both with procurement terms and capacity plans, then add the cost of waiting for usable evidence. A cheaper build that misses the next planning cycle may be the more expensive decision.
Run the vendor in shadow mode beside existing reporting before managers use its rankings to allocate work. Reconcile sampled GitHub or GitLab events against its exports, test whether Jira classifications survive correction, and calculate the primary outcome outside the vendor interface. Grafana and Prometheus can remain sources for service behavior, but they should not be treated as proof of engineering effectiveness because request latency does not identify the decision that produced it.
Write the exit test into the trial agreement. Buy if the platform passes the lineage gate, reproduces the independently calculated outcome and leads to documented decisions that improve the pilot relative to its comparison without an unacceptable delivery slowdown. Build if it fails on a requirement an internal prototype demonstrably satisfies, and the expected value of that requirement exceeds the build and maintenance cost. This rule is disputable, but it protects the CTO from funding a custom platform merely because the team prefers owning its tools.
Start by selecting one release decision and pulling a small sample of its recent production changes. Ask an engineer and an analyst to trace each change through deployment, defect classification and repair time, recording every missing join. That exercise supplies the first vendor test and the first internal-build estimate. If the chain cannot be reconstructed, fix it before asking any dashboard to prove a return.
